Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer

(2018) Lobna Ouldamer et al.   SURGICAL ONCOLOGY-OXFORD

Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting

(2018) Thorsten Kühn et al.   Breast Care

Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy

(2018) Sanaz Samiei et al.   ANNALS OF SURGERY

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

(2018) Jean-Marc Classe et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

(2017) Audree B. Tadros et al.   JAMA Surgery

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment

(2016) V. Galimberti et al.   EJSO

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

(2016) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

(2015) V. Bossuyt et al.   ANNALS OF ONCOLOGY

The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: A systematic review and meta-analysis

(2015) T.J.A. van Nijnatten et al.   EJSO

Regional Nodal Irradiation in Early-Stage Breast Cancer

(2015) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer

(2014) Judy C. Boughey et al.   ANNALS OF SURGERY

Arm lymphoedema after axillary surgery in women with invasive breast cancer

(2014) H. Sackey et al.   BRITISH JOURNAL OF SURGERY

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?

(2012) M.W.H. Leenders et al.   BREAST

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

(2012) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer

(2011) Soley Bayraktar et al.   CANCER

Second Primary Ipsilateral Breast Cancer With Contralateral Axillary Involvement: A Case Report and Literature Review

(2011) Christina I. Herold et al.   Clinical Breast Cancer

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

(2008) Jean-Marc Classe et al.   JOURNAL OF CLINICAL ONCOLOGY